4
Changes in Ownership
Aclaris Therapeutics, Inc. Filed Acc 0001209191-21-007372
Chief Legal Officer gave up 1,318 shares (to pay taxes)
- Chief Legal Officer acquired 3,875 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Ali-Jackson Kamil Chief Legal Officer | 2021-02-01 | Option exercise | +3,875 | 127,964 | D | ||
| Ali-Jackson Kamil Chief Legal Officer | 2021-02-01 | Shares withheld for taxes | −1,318 | $21.35 | $28,139 | 126,646 | D |
| Derivatives | |||||||
| Ali-Jackson Kamil Chief Legal Officer | 2021-02-01 | Option exercise · Restricted Stock Units | −3,875 | 3,875 | D | ||
Loading xslF345X03/doc4.xml…